---
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/286928655.md"
description: "Onconetix shares are trading lower after the company announced a 1-for-10 reverse stock split."
datetime: "2026-05-19T12:49:44.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/286928655.md)
  - [en](https://longbridge.com/en/news/286928655.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/286928655.md)
---

# 

Onconetix shares are trading lower after the company announced a 1-for-10 reverse stock split.

### Related Stocks

- [ONCO.US](https://longbridge.com/en/quote/ONCO.US.md)
- [IBB.US](https://longbridge.com/en/quote/IBB.US.md)
- [FBT.US](https://longbridge.com/en/quote/FBT.US.md)
- [SBIO.US](https://longbridge.com/en/quote/SBIO.US.md)
- [VHT.US](https://longbridge.com/en/quote/VHT.US.md)
- [XBI.US](https://longbridge.com/en/quote/XBI.US.md)
- [LABU.US](https://longbridge.com/en/quote/LABU.US.md)
- [BBH.US](https://longbridge.com/en/quote/BBH.US.md)

## Related News & Research

- [Onconetix Advances Proclarix Clinical Validation and Market Expansion](https://longbridge.com/en/news/286404226.md)
- [Alkermes reports encouraging data from Phase III study of Lumryz](https://longbridge.com/en/news/286349759.md)
- [Enanta Pharma's RSV Bet And Immunology Ambitions](https://longbridge.com/en/news/286895623.md)
- [Relay's treatment shown to shrink vascular malformations in mid-stage trial](https://longbridge.com/en/news/286890329.md)
- [NeOnc Advances Glioma Programs and Strengthens Financial Position](https://longbridge.com/en/news/286826865.md)